Contact
Get in touch.
For investor, partnering, scientific, or media inquiries.
Details
NeuroNova Therapeutics, LLC
10903 Indian Trail, Suite 301
Dallas, TX 75229
harrison.mirzaei@neuronovatherapeutics.com
214-263-7733
Suspected adverse events involving marketed hydralazine products can be reported to FDA MedWatch (1-800-FDA-1088). You may also notify us at the email above.
